Showing 501 - 520 results of 601 for search '"Gynaecology"', query time: 0.06s Refine Results
  1. 501
  2. 502
  3. 503
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508

    Practice and factors affecting informed consent among healthcare workers for major surgical procedures at Gurage zone hospitals, South Ethiopia, 2022: a facility-based cross-sectio... by Haimanot Abebe, Bitew Tefera Zewudie, Yibeltal Mesfin, Shegaw Geze Tenaw, Daniel Tsega, Bogale Chekole, Zebene Mekonnen, Shegaw Tesfa Mengist, Agere Aynalem, Tadele Lankrew, Yihenew Sewale, Muche Argaw, Tadesse Sahle

    Published 2025-01-01
    “…Objective This study aimed to assess the informed consent practice process and associated factors among healthcare workers for major surgical procedures at Gurage zone hospitals, in 2022.Methods and materials Institution-based cross-sectional study was employed.Settings This study was conducted in Gurage zone hospitals.Participants All healthcare workers who have been working in Gurage zone hospitals of surgical, operation rooms and obstetrics/gynaecology wards had exposure to patients who had undergone surgery during the study periodOutcome The primary outcome of the study was the practice of informed consent practice among healthcare workers in Gurage zone hospitals.Result A total of 448 study participants were involved in this study giving a response rate of 98%. …”
    Get full text
    Article
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513

    Efficacy and safety of NeoAdjuvant chemotherapy with or without tIslelizumab followed by debulking surgery for oVarian cancEr (NAIVE study) in China: study protocol of an open-labe... by Ying Zhu, Jianwei Zhou, Zhigang Zhang, Jiaojiao Zhang, Jing Fei, Xiaoqing Zhu

    Published 2025-02-01
    “…The NeoAdjuvant chemotherapy with or without tIslelizumab followed by debulking surgery for oVarian cancEr(NAIVE) study aims to assess the clinical efficacy and safety of NACT in combination with tislelizumab (a monoclonal antibody for programmed cell death protein 1) for advanced EOC.Methods and analysis The NAIVE study is an investigator-initiated, prospective, single-centre, open-label, randomised controlled trial for advanced EOC with the International Federation of Gynaecology and Obstetrics (FIGO) stage IIIc with a Suidan CT score of 3 or greater or a Fagotti laparoscopic score of 8 or greater; or FIGO stage IV. …”
    Get full text
    Article
  14. 514
  15. 515
  16. 516
  17. 517
  18. 518
  19. 519

    Impact of Mobile Health (mHealth) Use by Community Health Workers on the Utilization of Maternity Care in Rural Malawi: A Time Series Analysis by Kachimanga C, Ng’ambi WF, Kazinga D, Ndarama E, Amulele MA, Munyaneza F, Abejirinde IOO, van den Akker T, Kulinkina AV

    Published 2025-01-01
    “…Chiyembekezo Kachimanga,1,2 Wingston Felix Ng’ambi,3 Doctor Kazinga,1 Enoch Ndarama,4 Mercy Ambogo Amulele,5 Fabien Munyaneza,1 Ibukun-Oluwa O Abejirinde,6,7 Thomas van den Akker,2,8 Alexandra V Kulinkina1,9,10 1Partners in Health Malawi, Neno, Malawi; 2Athena Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 3Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences, Lilongwe, Malawi; 4Ministry of Health, Neno, Malawi; 5Medic, Nairobi, Kenya; 6Women College Hospital Institute for Health System Solutions and Virtual Care, Toronto, ON, Canada; 7Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; 8Department of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, Netherlands; 9Swiss Tropical and Public Health Institute, Allschwil, Switzerland; 10University of Basel, Basel, SwitzerlandCorrespondence: Chiyembekezo Kachimanga, Partners in Health Malawi, Post Office Box 56, Neno, Malawi, Email chembekachimanga@yahoo.co.ukPurpose: Maternal mortality in Malawi is high, with low coverage of maternity care being a contributing factor. …”
    Get full text
    Article
  20. 520